Chinese
Japan
English
66 customized services results for
About Us
Proprietary PowerS™-DNA⁺ Strain
ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South Korea
ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs
In Vitro Pharmacology
ProBio Signs Collaboration Agreement with Cell Resources Corporation, a Subsidiary of Alfresa Holdings Corporation for Cell Therapy Development
Lentiviral Vector CDMO Services
Global Biologics and CGT Symposium 2023- South Korea
Bioanalytical Development
Fc Engineering Service